Sanofi ThiNKs Scribe’s CRISPR Approach Can Advance Its NK Cell Therapy Goals

 
• By Joseph Haas
  
Cancer cell therapy
Sanofi will call on Scribe's gene-editing expertise for its NK cancer cell therapy efforts • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business